Elixinol Global Limited Annual Report 2020

Group Note 2020 $’000 2019 $’000 Cash flows from operating activities Receipts from customers (inclusive of GST) 14,095 33,179 Payments to suppliers and employees (inclusive of GST) (37,120) (84,579) Government grants 6 365 – Interest received 100 679 Interest and other finance costs paid (15) (138) Income taxes paid (46) (207) Net cash used in operating activities 36 (22,621) (51,066) Cash flows from investing activities Net cash acquired on purchase of subsidiaries – 209 Payments for equity accounted investments – (7,157) Payments for property, plant and equipment (295) (9,943) Payments for intangibles (33) (1,203) Proceeds from disposal of business 230 13 Proceeds from disposal of property, plant and equipment 2,652 149 Net cash from/(used in) investing activities 2,554 (17,932) Cash flows from financing activities Proceeds from issue of shares 22 31,478 50,000 Share issue transaction costs 22 (2,519) (2,827) Repayment of lease liabilities (1,414) (729) Net cash from financing activities 27,545 46,444 Net (decrease)/increase in cash and cash equivalents 7,478 (22,554) Cash and cash equivalents at the beginning of the financial year 20,373 42,922 Effects of exchange rate changes on cash and cash equivalents (108) 5 Cash and cash equivalents at the end of the financial year 10 27,743 20,373 The above consolidated statement of cash flows should be read in conjunction with the accompanying notes Consolidated Statement of Cash Flows for the year ended 31 December 2020 F INANCI AL REPORT Company Overview Financial Report Shareholder Information FY2020 Milestones 41 Strategy and Market Update